Articles > Newspapers > U.S. Newspapers, Major Markets > Deseret News (Salt Lake City) articles > September 2008

Article: Vytorin-cancer link can't be ruled out, doctors say

Article from:
Deseret News (Salt Lake City)
Article date:
September 3, 2008
Author:
Copyright

MUNICH, Germany -- Results so far from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with caution until more is known, editors of a leading medical journal urged Tuesday.

The New England Journal of Medicine published results online from one study and an analysis of partial results from two others. They also were presented at a cardiology conference in Munich.

Vytorin is a combination of Merck's Zocor, a long-sold statin drug, and Schering-Plough's Zetia, a newer type of medicine that lowers cholesterol in a different way.

The possible cancer risk unexpectedly arose in July, ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Data Analysis Showed VYTORIN(R) (ezetimibe/simvastatin) ...
Business Wire;  March 13, 2006 ;     700+ words ... ... new analysis presented today VYTORIN(R) (ezetimibe/simvastatin ... according to the American Heart Association.(1) Studies of CRP have ... CRP reductions, we saw that VYTORIN lowered LDL cholesterol and ... Zocor 10, 20, 40 or 80 mg, VYTORIN 10/10, 10/20, 10/40 ...

Article: New Study Showed VYTORIN(R) (ezetimibe/simvastatin) ...
Business Wire;  June 18, 2006 ;     700+ words ... ... ISA 2006) meeting in Rome. VYTORIN, which contains ezetimibe ... including cholesterol from food. VYTORIN is marketed as INEGY outside ... recommendations from the American Heart Association and the American College of ... of six treatment groups. VYTORIN provided significantly greater ...

Article: Study: No proof of Vytorin link to cancer
AP Worldstream;  September 2, 2008 ;     700+ words ... ... was no evidence implicating Vytorin, which millions of people ... doctors were convinced that Vytorin is risk-free. I think the ... spokesman for the American Heart Association. Tomaselli was not connected ... incidence of cancer in patients on Vytorin. At that point, Sir Richard ...

Article: REPEAT/New Study Showed VYTORIN(R) (ezetimibe/simvastatin) ...
Business Wire;  June 19, 2006 ;     700+ words ... ... ISA 2006) meeting in Rome. VYTORIN, which contains ezetimibe ... including cholesterol from food. VYTORIN is marketed as INEGY outside ... recommendations from the American Heart Association and the American College of ... of six treatment groups. VYTORIN provided significantly greater ...

Article: FDA backs Vytorin after finishing study review
AP Online;  January 8, 2009 ;     700+ words ... ... study that hammered Vytorin sales. A statement ... said former American Heart Association President Dr. Valentin ... Gardner, the current heart association president, said he ... Patients who are taking Vytorin without difficulty ...

Article: Doctors say Vytorin-cancer link can't be ruled out
AP Online;  September 2, 2008 ;     700+ words ... ... not convinced that Vytorin is safe. The jury ... spokesman for the American Heart Association. He was not connected ... They were either given Vytorin or a placebo in hopes ... Merck. The American Heart Association also accepts funding ... should not stop taking Vytorin because the ...

Article: Merck/Schering-Plough Pharmaceuticals Announces New Clinical ...
Business Wire;  November 9, 2004 ;     700+ words ... ... Large Trial to Evaluate VYTORIN(TM) in Reducing Major Cardiovascular ... that will be conducted for VYTORIN(TM) (ezetimibe/simvastatin ... According to the American Heart Association, it is estimated that approximately ... indications and contraindication for VYTORIN VYTORIN is indicated ...

Article: New Analysis in Patients with Type 2 Diabetes from Trial with ...
Business Wire;  June 13, 2005 ;     700+ words ... ... prespecified analysis of the VYVA (VYtorin Versus Atorvastatin) trial ... analysis, results showed that VYTORIN provided 56 percent reduction ... according to the American Heart Association. At the most commonly used ... 59 diabetic patients taking VYTORIN 10/20 mg, reduced their ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives